DarioHealth Corp (NASDAQ: DRIO)’s stock price has gone decline by -13.12 in comparison to its previous close of 0.84, however, the company has experienced a -8.25% decrease in its stock price over the last five trading days. prnewswire.com reported 2024-11-21 that Company expects to reach an estimated total of 25 new client signings in 2024, representing an approximate 35% growth in client base compared to 2023 NEW YORK, Nov. 21, 2024 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, announced today the signing of four contracts with self-insured employers that are expected to go live in the first quarter of 2025. Dario has added four new employer contracts to the 2025 book of business, continuing the business momentum in the Business-to-Business-to-Consumer (B2B2C) channel and securing recurring revenue from these accounts starting in the first quarter of 2025.
Is It Worth Investing in DarioHealth Corp (NASDAQ: DRIO) Right Now?
DRIO has 36-month beta value of 1.50. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for DRIO is 27.52M, and currently, short sellers hold a 6.67% ratio of that float. The average trading volume of DRIO on November 26, 2024 was 83.32K shares.
DRIO’s Market Performance
DRIO stock saw a decrease of -8.25% in the past week, with a monthly decline of -24.33% and a quarterly a decrease of -13.65%. The volatility ratio for the week is 12.31%, and the volatility levels for the last 30 days are 8.96% for DarioHealth Corp (DRIO). The simple moving average for the past 20 days is -16.10% for DRIO’s stock, with a -41.66% simple moving average for the past 200 days.
Analysts’ Opinion of DRIO
Many brokerage firms have already submitted their reports for DRIO stocks, with Alliance Global Partners repeating the rating for DRIO by listing it as a “Buy.” The predicted price for DRIO in the upcoming period, according to Alliance Global Partners is $8.75 based on the research report published on May 13, 2022 of the previous year 2022.
Cowen, on the other hand, stated in their research note that they expect to see DRIO reach a price target of $31. The rating they have provided for DRIO stocks is “Outperform” according to the report published on April 22nd, 2021.
Stifel gave a rating of “Buy” to DRIO, setting the target price at $30 in the report published on March 23rd of the previous year.
DRIO Trading at -22.64% from the 50-Day Moving Average
After a stumble in the market that brought DRIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.77% of loss for the given period.
Volatility was left at 8.96%, however, over the last 30 days, the volatility rate increased by 12.31%, as shares sank -26.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.70% lower at present.
During the last 5 trading sessions, DRIO fell by -8.25%, which changed the moving average for the period of 200-days by -64.20% in comparison to the 20-day moving average, which settled at $0.8749. In addition, DarioHealth Corp saw -57.33% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DRIO starting from Nelson Steven Charles, who purchase 5,000 shares at the price of $0.91 back on Nov 12 ’24. After this action, Nelson Steven Charles now owns 55,000 shares of DarioHealth Corp, valued at $4,546 using the latest closing price.
Nelson Steven Charles, the Chief Commercial Officer of DarioHealth Corp, purchase 5,000 shares at $0.84 during a trade that took place back on Sep 10 ’24, which means that Nelson Steven Charles is holding 45,000 shares at $4,221 based on the most recent closing price.
Stock Fundamentals for DRIO
Current profitability levels for the company are sitting at:
- -2.58 for the present operating margin
- 0.4 for the gross margin
The net margin for DarioHealth Corp stands at -1.5. The total capital return value is set at -0.65. Equity return is now at value -50.90, with -29.75 for asset returns.
Based on DarioHealth Corp (DRIO), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at -1.36. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is -40.25.
Currently, EBITDA for the company is -53.49 million with net debt to EBITDA at -0.28. When we switch over and look at the enterprise to sales, we see a ratio of 1.73. The receivables turnover for the company is 2.75for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.57.
Conclusion
To put it simply, DarioHealth Corp (DRIO) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
